Recruiting EARLY_PHASE1 INTERVENTIONAL 3-arm NCT05824338

Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery (SASS)

Sponsor: Fraser Health

Conditions Anesthesia, Spinal Bupivacaine Neurosurgery Ropivacaine

Interventions General anesthesia for lumbar surgery Spinal anesthesia for lumbar surgery: bupivacaine Spinal anesthesia for lumbar surgery: ropivacaine

Updated 5 times since 2023 Last updated: Oct 4, 2024 Started: Aug 27, 2024 Primary completion: Jul 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Anesthesia, Spinal and Bupivacaine and is currently actively recruiting participants. Fraser Health leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Nov 2024 — Present [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Dec 2023 — Jul 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
May 2023 — Dec 2023 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fraser Health

Data source: Fraser Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Westminster, Canada
• Port Moody, Canada